Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Bohn JP"'
Autor:
Bohn JP; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Stolzlechner V; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Göbel G; Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Innsbruck, Austria., Pirklbauer M; Department of Internal Medicine IV, Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Steiner N; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug 21, pp. 1-8. Date of Electronic Publication: 2024 Aug 21.
Autor:
Prantl L; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Heider P; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Bergmeister L; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Calana K; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Bohn JP; Department of Internal Medicine V, Hematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Hematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Banki Z; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Bosch A; 2bind GmbH, Regensburg, Germany., Plach M; 2bind GmbH, Regensburg, Germany., Huber G; Sirion Biotech GmbH, Gräfelfing, Germany., Schrödel S; Sirion Biotech GmbH, Gräfelfing, Germany., Thirion C; Sirion Biotech GmbH, Gräfelfing, Germany., Stoiber H; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.; Lysomab GmbH, Schwaz, Austria.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jul 22; Vol. 15, pp. 1379023. Date of Electronic Publication: 2024 Jul 22 (Print Publication: 2024).
Autor:
Plattner C; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria., Sallaberger S; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria., Bohn JP; Department of Internal Medicine V - Haematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Zavadil C; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria., Keller F; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria., Soleiman A; INNPATH, Institute of Pathology, Tirol Kliniken Innsbruck, Innsbruck, Austria., Tiefenthaler M; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria., Mayer G; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria., Pirklbauer M; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria.
Publikováno v:
Clinical kidney journal [Clin Kidney J] 2024 Apr 11; Vol. 17 (5), pp. sfae109. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024).
Autor:
Simon F; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Bohn JP; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Innsbruck, Austria. Jan-Paul.Bohn@i-med.ac.at.
Publikováno v:
Current oncology reports [Curr Oncol Rep] 2023 Oct; Vol. 25 (10), pp. 1181-1189. Date of Electronic Publication: 2023 Sep 08.
Autor:
Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. DChihara@mdanderson.org., Gras L; EBMT Statistical Unit., Zinger N; EBMT Study Unit, Leiden., Kröger N; University Hospital Eppendorf, Hamburg., Mayer J; University Hospital Brno, Brno, Czech Republic., Passweg J; University Hospital | Basel, Basel., De Latour RP; Hopital St. Louis 207, Paris., Byrne J; Nottingham University, Nottingham., Krüger W; Klinik fuer Innere Medizin C, Greifswald., Bohn JP; University Hospital Innsbruck, Innsbruck., Platzbecker U; Medical Clinic and Policinic 1, Leipzig., Blau IW; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin., Bonifazi F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna Italy., Helbig G; Silesian Medical University, Katowice., McDonald A; Alberts Cellular Therapy, Netcare Pretoria east Hospital, Pretoria., Mistrik M; University Hospital, Bratislava, Slovak Republic., Mohty M; Sorbonne University, Saint-Antoine Hospital, AP-HP, and INSERM UMRs 938, Paris., Ram R; Tel Aviv Sourasky Medical Center and Soursky Faculy of Medicine, Aviv., Sanz J; University Hospital La Fe, Valencia., Llamas CV; Hospital Universitario Donostia, S Sebastian., Kreitman RJ; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Hayden PJ; Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin, Ireland., McLornan D; University College London Hospitals NHS Trust, London., Tournilhac O; Department of Hematology and Cell Therapy, CHU Estaing, Université Clermont Auvergne, Clermont-Ferrand., Van Gelder M; University Hospital Maastricht, Maastricht, Netherlands., Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille.
Publikováno v:
Haematologica [Haematologica] 2023 Jun 01; Vol. 108 (6), pp. 1676-1679. Date of Electronic Publication: 2023 Jun 01.
Autor:
Bohn JP; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria., Fiala A; Department of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria., Bachmann S; Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria., Irsara C; Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Feistritzer C; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
Publikováno v:
Therapeutic advances in hematology [Ther Adv Hematol] 2022 Jul 26; Vol. 13, pp. 20406207221104595. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).
Autor:
Bohn JP; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, A-6020 Innsbruck, Austria., Neururer S; Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, A-6020 Innsbruck, Austria., Pirklbauer M; Department of Internal Medicine IV, Nephrology and Hypertension, Medical University of Innsbruck, A-6020 Innsbruck, Austria., Pircher A; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, A-6020 Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Feb 28; Vol. 14 (5). Date of Electronic Publication: 2022 Feb 28.
Autor:
Bohn JP; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, A-6020 Innsbruck, Austria., Dietrich S; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Feb 15; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 15.
Autor:
Bohn JP; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria.
Publikováno v:
Memo [Memo] 2022; Vol. 15 (2), pp. 121-124. Date of Electronic Publication: 2022 Apr 14.
Autor:
Bohn JP; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Salcher S; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Pircher A; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Untergasser G; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Experimental Oncogenomic Group, Tyrolean Cancer Research Institute, 6020 Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Department of Hematology and Oncology, Medical Clinic 3, University Hospital Bonn, 53127 Bonn, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 21; Vol. 22 (15). Date of Electronic Publication: 2021 Jul 21.